Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

Related Articles by Review for PubMed (Select 18926586)

1.

Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes: what to add--insulin glargine or pioglitazone?

Dorkhan M, Frid A, Groop L.

Diabetes Res Clin Pract. 2008 Dec;82(3):340-5. doi: 10.1016/j.diabres.2008.09.009. Epub 2008 Oct 15.

PMID:
18926586
2.

Dosing of insulin glargine in the treatment of type 2 diabetes.

Barnett A.

Clin Ther. 2007 Jun;29(6):987-99. Review.

PMID:
17692716
3.

Long-term glycaemic control with pioglitazone in patients with type 2 diabetes.

Campbell IW.

Int J Clin Pract. 2004 Feb;58(2):192-200. Review. Erratum in: Int J Clin Pract. 2004 Oct;58(10):993.

PMID:
15055868
4.

Clinical inquiries. What is the role of combination therapy (insulin plus oral medication) in type 2 diabetes?

Eskesen S, Kelsberg G, Hitchcock K, Lo V.

J Fam Pract. 2006 Nov;55(11):1001-3. Review.

PMID:
17090364
5.
6.

Pioglitazone: a review of its use in type 2 diabetes mellitus.

Waugh J, Keating GM, Plosker GL, Easthope S, Robinson DM.

Drugs. 2006;66(1):85-109. Review. Erratum in: Drugs. 2006;66(3):340-1.

PMID:
16398569
7.
8.

Metformin and pioglitazone: Effectively treating insulin resistance.

Staels B.

Curr Med Res Opin. 2006;22 Suppl 2:S27-37. Review.

PMID:
16914073
9.
10.
11.

Effects of pioglitazone on lipid and lipoprotein metabolism.

Betteridge DJ.

Diabetes Obes Metab. 2007 Sep;9(5):640-7. Review.

PMID:
17697057
12.

Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.

Clar C, Royle P, Waugh N.

PLoS One. 2009 Jul 1;4(7):e6112. doi: 10.1371/journal.pone.0006112. Review.

13.

Management of hyperglycemia in minority children with type 2 diabetes mellitus.

Castells S.

J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:531-40. Review.

PMID:
12017228
14.

Initiating insulin in patients with type 2 diabetes.

Aoki TJ, White RD.

J Fam Pract. 2007 Aug;56(8 Suppl Hot Topics):S12-20. Review.

PMID:
18667139
15.
16.

Pioglitazone hydrochloride/glimepiride.

Blake EW.

Drugs Today (Barc). 2007 Jul;43(7):487-97. Review.

PMID:
17728849
17.

The role of thiazolidinediones in the treatment of patients with type 2 diabetes mellitus.

Mooradian AD, Chehade J, Thurman JE.

Treat Endocrinol. 2002;1(1):13-20. Review.

PMID:
15765617
18.

Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes.

Erdmann E.

Int J Cardiol. 2006 Feb 15;107(2):147-53. Epub 2005 Jun 22. Review.

PMID:
15975669
19.

Thiazolidinediones and type 2 diabetes: new drugs for an old disease.

O'Moore-Sullivan TM, Prins JB.

Med J Aust. 2002 Apr 15;176(8):381-6. Review. Erratum in: Med J Aust 2002 Oct 7;177(7):396.

PMID:
12041635
20.

Can thiazolidinediones delay disease progression in type 2 diabetes?

Leiter LA.

Curr Med Res Opin. 2006 Jun;22(6):1193-201. Review.

PMID:
16846552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk